1110 — Kingworld Medicines Cashflow Statement
0.000.00%
Last trade - 00:00- HK$311.25m
- HK$571.69m
- CNY1.08bn
Annual cashflow statement for Kingworld Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 69.8 | 70.9 | 69.4 | 67.6 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1.07 | 25.4 | 7.04 | 9.64 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 27.7 | -7.26 | -30.1 | 71.1 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 133 | 124 | 81.2 | 187 | — |
| Capital Expenditures | -20.3 | -9.93 | -58.3 | -93.5 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 12.6 | 7.17 | 7.48 | 9.46 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.68 | -2.76 | -50.8 | -84 | — |
| Financing Cash Flow Items | -24.9 | -37.1 | -13.2 | -58.2 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -174 | 25 | -87.2 | -51.3 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -47.2 | 137 | -62.9 | 54.2 | — |